English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31907301    ???header.onlineuser??? :  1045
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 506-530 of 1137  (46 Page(s) Totally)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-12-02T02:34:18Z Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Huang C.-T.; Yen R.-F.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:17Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:15Z Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women Lu T.-P.;Tsai M.-H.;Lee J.-M.;Hsu C.-P.;Chen P.-C.;Lin C.-W.;Shih J.-Y.;Pan-Chyr Yang;Hsiao C.K.;Lai L.-C.;Chuang E.Y.; Lu T.-P.; Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; Lin C.-W.; Shih J.-Y.; PAN-CHYR YANG; Hsiao C.K.; Lai L.-C.; Chuang E.Y.
臺大學術典藏 2020-12-02T02:34:13Z Epidermal growth factor receptor mutations in small cell lung cancer: A brief report Shiao T.-H. ;Chang Y.-L. ;Yu C.-J. ;Chang Y.-C. ;Hsu Y.-C. ;Chang S.-H. ;Shih J.-Y. ;Pan-Chyr Yang; Shiao T.-H.; Chang Y.-L.; Yu C.-J.; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:12Z The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma Kuo Y.-W. ;Jerng J.-S. ;Shih J.-Y. ;Chen K.-Y. ;Yu C.-J. ;Pan-Chyr Yang; Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:10Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Chang Y.-C.;Hsu Y.-C.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:10Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:09Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.;Yu C.-J.;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:09Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:06Z The EMT regulator slug and lung carcinogenesis Shih J.-Y.;Pan-Chyr Yang; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:05Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:04Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:34:04Z Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation Lu C.-H.; Hsiao C.-H.; Chang Y.-C.; Lee J.-M.; Shih J.-Y.; Wu L.-A.; Yu C.-J.; Liu H.-M.; Shih T.T.-F.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:03Z Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer Su K.-Y.; Chen H.-Y.; Li K.-C.; Kuo M.-L.; Yang J.C.-H.; Chan W.-K.; Ho B.-C.; Chang G.-C.; Shih J.-Y.; Yu S.-L.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:03Z Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment Chung K.-P.; Huang Y.-T.; Chang Y.-L.; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:03Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:01Z RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Tsai T.-H.; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:00Z Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial Yang J.C.H.; Shih J.-Y.; Su W.-C.; Hsia T.-C.; Tsai C.-M.; Ou S.H.I.; Yu C.-J.; Chang G.-C.; Ho C.-L.; Sequist L.V.; Dudek A.Z.; Shahidi M.; Cong X.J.; Lorence R.M.; PAN-CHYR YANG; Miller V.A.
臺大學術典藏 2020-12-02T02:33:59Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:59Z Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors Hsu C.-L.; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:55Z ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors Huang C.-P.; Tsai M.-F.; Chang T.-H.; Tang W.-C.; Chen S.-Y.; Lai H.-H.; Lin T.-Y.; Yang J.C.H.; PAN-CHYR YANG; Shih J.-Y.; Lin S.-B.
臺大學術典藏 2020-12-02T02:33:55Z Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy Hwang C.-L.; Yu C.-J.; Shih J.-Y.; Pan-Chyr Yang; Wu Y.-T.; Hwang C.-L.; Yu C.-J.; Shih J.-Y.; PAN-CHYR YANG; Wu Y.-T.
臺大學術典藏 2020-12-02T02:33:52Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:33:49Z Survival of lung adenocarcinoma patients with malignant pleural effusion Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:33:46Z Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; PAN-CHYR YANG; Shih J.-Y.; Tsai T.-H.; PAN-CHYR YANG et al.

Showing items 506-530 of 1137  (46 Page(s) Totally)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
View [10|25|50] records per page